NewsRoom Articles - NetworkNewsWire

FridayDec 08, 2023 10:30 am

Astiva Health Is ‘One to Watch’

Astiva Health currently offers Medicare Advantage health plans in two heavily populated southern California counties; the company is planning to expand its operation in northern California and other states The company serves and supports an underserved Vietnamese-American population The company plans to expand its successful culturally responsive strategies to serve other ethnic populations Astiva Health has strategically positioned itself in a region with a dynamic and diverse population Astiva’s forward-thinking investment in sustainable growth aligns with evolving healthcare dynamics, ensuring the company remains resilient and transformative in meeting the diverse needs of communities Astiva Health is a dynamic and innovative…

FridayDec 08, 2023 9:45 am

SuperCom Ltd. (NASDAQ: SPCB) Applauds Israel’s Passage of Electronic Monitoring Bracelet Law

Israel passed the Electronic Monitoring Bracelet Law in June 2023, allowing courts to monitor abusers through electronic monitoring (EM), a practice already employed in a growing number of other countries SuperCom's PureSecurity Electronic Monitoring Suite has been used in other countries to monitor domestic violence offenders, including use as part of Romania’s first electronic monitoring program The company is seen at the forefront when it comes to advances in EM technology for domestic violence applications In late June 2023, the Israeli government passed the Electronic Monitoring Bracelet Law, which National Security Minister Itamar Ben-Gvir proposed. The purpose of the law…

FridayDec 08, 2023 9:00 am

The 2023 Nobel Prize in Chemistry’s Spotlight on Nanotechnology Shines Light on Clene Inc. (NASDAQ: CLNN) Efforts to Develop Catalytically Active Nanoparticles

The 2023 Nobel Prize in Chemistry, awarded to Moungi G. Bawendi, Louis E. Brus, and Aleksey Yekimov for their efforts in discovering and synthesizing quantum dots, recognizes the power of nanotechnology Nanoscience is the study of structures and molecules whose sizes range between 1 and 100 nm, while nanotechnology is the technology that utilizes nanoscience in practical applications The applications of nanotechnology are wide-ranging, from industrial-scale catalysis and modern electronics to precision medicine and quantum technology Clene Inc., a late clinical-stage biopharmaceutical company, has applied nanotechnology alongside other science concepts in the development of catalytically active nanocrystals The catalytic activities…

ThursdayDec 07, 2023 10:30 am

GEMXX Corp. (GEMZ) Releases Positive Q2 2023 Results, Provides 2023 Business and Mining Updates

GEMXX reported significant growth in its Q2 2023 revenue and net income, with the company anticipating additional growth and increased production of its gold assets in 2024 GEMXX, in partnership with Crazy Horse Mining Inc., proved the commercial viability of the Snow Creek gold mine and is looking to similarly prove the viability of the Rosella Creek gold asset in 2024 For the balance of 2023 and into 2024, the company is targeting additional acquisitions, more mine production, and more revenues, and plans to expand gemstone and jewelry production by 300% in 2024 GEMXX (OTC: GEMZ), a company specializing in…

ThursdayDec 07, 2023 9:45 am

SenesTech Inc. (NASDAQ: SNES) Posts Strong 44% YOY Revenue Growth for Q3 2023; Looks to Accelerate This Growth with New Product Launch

SenesTech, experts in animal fertility control, posted a 44% YOY revenue growth for Q3 2023 Gross profit also saw 49% growth from $122,000 in 2022 to $175,000 in 2023 The growth was attributed to the company’s primary initiatives to drive sales, improve product quality, and expand product options The company looks to greatly accelerate growth with the launch of its Evolve Soft Bait, key to opening the huge professional rodent control market, and the first and only soft bait developed to control pest populations through technology that targets the population where it starts, without poisons SenesTech (NASDAQ: SNES), an animal…

ThursdayDec 07, 2023 9:00 am

Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FRA: GTD0) CEO Discusses Recent Hack of China’s Largest Financial Institution, How Sekur Suite of Services Is Designed to Help

This week's New to the Street episode revolves around a recent cyberattack targeting ICBC (Industrial and Commercial Bank of China Limited), the world's largest bank ICBC and its subsidiary, ICBC Financial Services, fell victim to a crippling ransomware attack, resulting in a system shutdown Sekur’s secure email solution operates exclusively on the company’s wholly-owned servers, safeguarding both senders and recipients, even if the latter is not a Sekur subscriber New to the Street TV, a leading financial and business news show, recently sat down with Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FRA: GTD0) CEO Alain Ghiai to discuss the…

WednesdayDec 06, 2023 11:15 am

Podcast: Jewelry Maker GEMXX Corp. (GEMZ) Enjoys Rapid Growth Thanks to Gold Interest, Focus on Vertical Mine-to-Market Integration

GEMXX Corporation is unique as a jewelry maker with important Canadian mining assets, supporting its mine-to-market operations dealing in gold and the rare Ammolite gemstone Amid recent market fluctuations, gold continues to maintain a strategic profile as an investment safe haven, with consumption continuing at a historic pace GEMXX is riding high on recent “explosive” revenue growth and a no long-term debt position, looking forward to fulfilling select goals to improve its overall production, uplisting to a major exchange and aggressively seeking out strategic acquisitions to add revenue and / or reduce its costs A new NetworkNewsAudio News Podcast and…

WednesdayDec 06, 2023 10:30 am

PaxMedica Inc. (NASDAQ: PXMD) Completes Key Type-B FDA Meeting, Discussing Positive Results from PAX-HAT-301 Study

During the live type-B meeting, PaxMedica discussed the positive results of the recent data from its PAX-HAT-301 study of suramin in Stage One HAT, also called African Sleeping Sickness The FDA is allowing PaxMedica to use previous data from early tests of suramin to begin developing the drug for use in current cases of HAT PaxMedica received constructive feedback, which will aid in completing the remaining work necessary to file a New Drug Application (“NDA”), expected in the second half of 2024 The global ASD therapeutics market was valued at $1.93 billion in 2022 and is expected to reach $3.42…

WednesdayDec 06, 2023 9:45 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Advances Solution to Chinese Controls on REE Supply Chain

Strategic metals supply chain innovator Ucore Rare Metals Inc. has developed a proprietary technology it expects to improve rare earth element (“REE”) processing, and is preparing for commercial use of its solution The REE supply chain has become a matter of concern to Western governments as well as private industry because of the tremendous market dominance enjoyed by the People’s Republic of China and fears China will exploit that dominance with increasing export restrictions Ucore is currently demonstrating the ability of its RapidSX(TM) REE processing solution to match and / or exceed the capacity of industry-standard CSX processing technology while…

WednesdayDec 06, 2023 9:00 am

Mountain Top Properties Inc. (MTPP) Seeks to Shake Up Hamptons Real Estate Market

Mountain Top Properties is seeking to capitalize on the Hamptons real estate market through its maiden investment fund, Mountain Top Capital Fund I LLC In conjunction with renowned contractor, On Site Builder Construction, the fund will seek to acquire, build, renovate, and resell homes in the exclusive Long Island enclave Mountain Top Capital Fund have announced plans to raise up to $75 million to fund its commercial endeavours, with a significant amount of debt capital already secured to fund operations Brokers say that despite several slowing factors, the luxury market are still bidding and buying the Long Island beach homes…

Financial news and publishing for public and private companies

Contact us: 212.418.1217